Home / Inspections / 740776

FDA Inspection 740776 — Astellas Pharma US Inc.

Astellas Pharma US Inc. — FEI 1000036852

The FDA completed an inspection of Astellas Pharma US Inc. on August 23, 2011 in Northbrook, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 23, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Northbrook, IL (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Facility

Other inspections at this facility

  • 1217117 (OAI Mon Aug 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1108572 (VAI Fri Oct 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1058496 (NAI Fri Jun 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1030399 (NAI Fri Sep 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 864055 (NAI Wed Feb 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources